Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Clinical trial NCT01478477 · COMPLETED
Trial details
- NCT number
- NCT01478477
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-04
- Primary completion
- 2014-01-09
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.